• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示神经酰胺和脂肪酸引发肥胖相关免疫炎症反应的机制。

Unwrapping the mechanisms of ceramide and fatty acid-initiated signals leading to immune-inflammatory responses in obesity.

机构信息

Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

出版信息

Int J Biochem Cell Biol. 2021 Jun;135:105972. doi: 10.1016/j.biocel.2021.105972. Epub 2021 Apr 14.

DOI:10.1016/j.biocel.2021.105972
PMID:33864951
Abstract

Obesity is considered a global epidemic developed in part as a consequence of the overconsumption of high fat diets. One of the main negative outcomes of obesity is the development of low-grade chronic systemic inflammation, induced by dysregulated immune responses, which can lead to multiple obesity-related diseases. Ceramides are a group of bioactive lipids known to be elevated in obesity and obesity-associated conditions, including cardiovascular disease and type II diabetes. Ceramides may be key players in promoting an obesity-induced inflammatory environment due to their ability to activate key pathways such as Toll-like receptor 4 (TLR4) and NLR pyrin domain containing receptor 3 (Nlrp3), while studies have shown that inhibition of ceramide synthesis gives rise to an anti-inflammatory environment. N-3 polyunsaturated fatty acids (n-3 PUFA) have been of interest due to their anti-inflammatory actions and shown to have beneficial effects in obesity-related diseases. This review will highlight the impact of ceramides in promoting an obesity-induced inflammatory microenvironment and discuss how n-3 PUFA could potentially counteract these responses and have a regulatory effect promoting immune homeostasis.

摘要

肥胖被认为是一种全球性的流行疾病,部分是由于高脂肪饮食的过度摄入所致。肥胖的一个主要负面影响是低度慢性系统性炎症的发展,这是由失调的免疫反应引起的,可能导致多种与肥胖相关的疾病。神经酰胺是一组生物活性脂质,已知在肥胖和肥胖相关疾病中升高,包括心血管疾病和 2 型糖尿病。神经酰胺可能是促进肥胖诱导的炎症环境的关键因素,因为它们能够激活关键途径,如 Toll 样受体 4(TLR4)和 NLR 富含吡喃结构域蛋白 3(Nlrp3),而研究表明,神经酰胺合成的抑制会产生抗炎环境。由于 n-3 多不饱和脂肪酸 (n-3 PUFA) 具有抗炎作用,并显示在肥胖相关疾病中有有益的作用,因此它们引起了人们的兴趣。本综述将重点讨论神经酰胺在促进肥胖诱导的炎症微环境中的作用,并讨论 n-3 PUFA 如何可能抵消这些反应并具有促进免疫稳态的调节作用。

相似文献

1
Unwrapping the mechanisms of ceramide and fatty acid-initiated signals leading to immune-inflammatory responses in obesity.揭示神经酰胺和脂肪酸引发肥胖相关免疫炎症反应的机制。
Int J Biochem Cell Biol. 2021 Jun;135:105972. doi: 10.1016/j.biocel.2021.105972. Epub 2021 Apr 14.
2
Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity.肥胖中,巨噬细胞特异性从头合成神经酰胺对于炎性小体驱动的炎症和胰岛素抵抗并非必需。
J Biol Chem. 2015 Dec 4;290(49):29402-13. doi: 10.1074/jbc.M115.680199. Epub 2015 Oct 5.
3
Ceramides and mitochondrial fatty acid oxidation in obesity.肥胖中的神经酰胺与线粒体脂肪酸氧化
FASEB J. 2017 Apr;31(4):1263-1272. doi: 10.1096/fj.201601156R. Epub 2016 Dec 21.
4
Omega-3 polyunsaturated fatty acids reverse the impact of western diets on regulatory T cell responses through averting ceramide-mediated pathways.ω-3多不饱和脂肪酸通过避免神经酰胺介导的途径,逆转西方饮食对调节性T细胞反应的影响。
Biochem Pharmacol. 2022 Oct;204:115211. doi: 10.1016/j.bcp.2022.115211. Epub 2022 Aug 17.
5
The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.生酮饮食可通过减少脂肪生成、二酰基甘油积累和蛋白激酶 C 活性来预防雄性大鼠肝脏脂肪变性和胰岛素抵抗。
J Physiol. 2022 Sep;600(18):4137-4151. doi: 10.1113/JP283552. Epub 2022 Sep 4.
6
Fatty Acids and NLRP3 Inflammasome-Mediated Inflammation in Metabolic Tissues.脂肪酸与代谢组织中NLRP3炎性小体介导的炎症
Annu Rev Nutr. 2017 Aug 21;37:77-102. doi: 10.1146/annurev-nutr-071816-064836.
7
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice.脂多糖诱导的促炎受体 TLR4 介导的胰岛素抵抗需要饱和脂肪酸诱导的鞘氨醇生物合成在小鼠中。
J Clin Invest. 2011 May;121(5):1858-70. doi: 10.1172/JCI43378. Epub 2011 Apr 1.
8
A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.高比例的膳食 n-3/n-6 多不饱和脂肪酸通过抑制 TLR4 的激活改善肥胖相关的炎症和胰岛素抵抗。
Nutr Res. 2013 Oct;33(10):849-58. doi: 10.1016/j.nutres.2013.07.004. Epub 2013 Aug 9.
9
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.肥胖诱导的胰岛素抵抗发展过程中脂肪组织炎症的细胞和分子参与者。
Biochim Biophys Acta. 2014 Mar;1842(3):446-62. doi: 10.1016/j.bbadis.2013.05.017. Epub 2013 May 22.
10
Reappraisal of Adipose Tissue Inflammation in Obesity.重新评估肥胖症中的脂肪组织炎症。
Adv Exp Med Biol. 2024;1460:297-327. doi: 10.1007/978-3-031-63657-8_10.

引用本文的文献

1
Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes.神经酰胺 d18:1/24:1 可作为区分不良健康结局肥胖亚型的潜在生物标志物。
Lipids Health Dis. 2023 Oct 4;22(1):166. doi: 10.1186/s12944-023-01921-0.
2
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.非酒精性脂肪性肝病的创新治疗方法:了解您的患者是关键。
Int J Mol Sci. 2023 Jun 27;24(13):10718. doi: 10.3390/ijms241310718.
3
Ceramide in cerebrovascular diseases.脑血管疾病中的神经酰胺
Front Cell Neurosci. 2023 Jun 2;17:1191609. doi: 10.3389/fncel.2023.1191609. eCollection 2023.
4
Role of ceramides in diabetic foot ulcers (Review).神经酰胺在糖尿病足溃疡中的作用(综述)。
Int J Mol Med. 2023 Mar;51(3). doi: 10.3892/ijmm.2023.5229. Epub 2023 Feb 17.
5
Patients with Bacterial Sepsis Are Heterogeneous with Regard to Their Systemic Lipidomic Profiles.患有细菌性脓毒症的患者在其全身脂质组学特征方面存在异质性。
Metabolites. 2022 Dec 29;13(1):52. doi: 10.3390/metabo13010052.
6
Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease.探讨神经酰胺和鞘氨醇-1-磷酸在非酒精性脂肪性肝病中的作用和发病机制。
Int J Biol Sci. 2023 Jan 1;19(1):311-330. doi: 10.7150/ijbs.78525. eCollection 2023.
7
Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients.异基因干细胞移植受者移植前的系统脂质组学概况
Cancers (Basel). 2022 Jun 13;14(12):2910. doi: 10.3390/cancers14122910.
8
You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease.你无法免受在心脏代谢疾病中积累的神经酰胺的影响。
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Jun;1867(6):159125. doi: 10.1016/j.bbalip.2022.159125. Epub 2022 Feb 23.
9
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets.非酒精性脂肪性肝病的病理生理机制:从驱动因素到治疗靶点
Biomedicines. 2021 Dec 26;10(1):46. doi: 10.3390/biomedicines10010046.